Senior Director, Analytical Development
- Employer
- Precision BioSciences, Inc.
- Location
- Durham, NC, United States
- Start date
- Oct 23, 2019
View more
- Discipline
- Information Technology, Business/Data Analytics
- Required Education
- Associate Degree
- Position Type
- Full time
- Hotbed
- Bio NC
Job Details
Essential Duties and Responsibilities
Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of this position. This list contains the major duties and requirements of the job and is not all-inclusive. Incumbent(s) may be expected to perform role-related duties other than those contained in this document.
- As a leader of leaders, provide strategic and tactical direction across multiple laboratories and analytical modalities to develop a comprehensive understanding of genome-edited cell and gene therapy products from preclinical development through commercial launch
- As the functional head, maintain high autonomy and science-driven decision making throughout Product Sciences teams within the context of a matrixed development organization through processes that foster frictionless communication of analytical development timelines and risks, appropriate testing and data analytics turnaround standards, robust SME support for Quality, Technical Operations, Process Sciences, and Regulatory requests, and timely updates to Program and Project Teams
- Drive excellence in the execution and continuous improvement of appropriate laboratory controls for sample management, data integrity, analytical instrumentation, and reagent performance
- Review and approve IND, IMPD, BLA and MAA sections and participate in interactions with regulatory bodies throughout the product development lifecycle
- Maintain awareness of the current state of the field (literature, regulatory expectations and competitive surveillance), and contribute to the broader cell and gene therapy industry and academic ecosystem through publications and conference presentations
- Mentorship of a high-performing team of Directors, Associate Directors, Scientists, and Research Associates in the fundamentals of rigorous and sound analytical development and product characterization, including creating opportunities for continuous professional development
Qualifications
The requirements listed below are representative of the knowledge, skill, and/or ability required to perform this job successfully.
Education/Experience:
- PhD in chemical or biological sciences with 15+ years of biopharmaceutical experience, or equivalent
- Experience in all stages of analytical development and product characterization from preclinical through product licensure, including intra- and inter-company technology transfers, CRO/CDMO management, and the evaluation of novel analytical technologies
- Experience across a broad range of cellular, genomic, proteonomic, metabolomic, and biomolecular analytical methodologies including compendial methods, FACS, qPCR and ddPCR, NGS, cell-based potency assays, HPLC, and mass spectrometry
- Experience with the management and operations of BSL2 laboratories
- Expert proficiency deploying ICH principals for analytical method development, qualification, and validation
- Expert proficiency in the statistical design of experiment and large dataset analytics
- Expert proficiency streamlining the generation, review, and approval of test methods, development reports, qualification reports, stability protocols, and product characterization studies in support of technology transfers and IND/IMPD/BLA/MAA filings
- Fluency with global regulatory guidelines and requirements for advanced therapy medicinal products
- Fluency in the design and interpretation of accelerated and real-time drug product stability programs including forced degradation
- Experience providing analytical support to both early and late stage Process Sciences and MSAT teams is a strong plus
- Experience with analytical development for cell and gene therapies is a strong plus
- Experience with the evaluation of exploratory biomarkers is a strong plus
- Ability to explore creative approaches to accelerate analytical method development, evaluation of exploratory biomarkers, technology transfer, and comparability assessments
- Ability to thoughtfully balance the three pillars of Quality, Speed, and Cost for effective product development
- Outstanding leadership and management skills to inspire, coach, mentor, and grow a strong organization
- Instinctive personal alignment with Precisions values, mission and vision
Travel Requirements
- This position requires limited travel (5-10%)
Precision BioSciences is dedicated to improving life through its proprietary genome editing platform, ARCUS. Precision BioSciences leverages ARCUS in the development of its product candidates which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision BioSciences is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
Precision BioSciences provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable federal, state and local laws. Precision BioSciences complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.
Company
Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing and ex vivo allogeneic CAR T therapies with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly sophisticated edits for gene insertion and/or gene repair. Precision’s in vivo gene editing pipeline consists of wholly-owned preclinical candidates for primary hyperoxaluria type 1 (PBGENE-PH1), familial hypercholesteremia (PBGENE-PCSK9) and chronic hepatitis B (PBGENE-HBV). It has also partnered with Lilly to develop candidates for Duchenne muscular dystrophy and two other programs targeting the liver and CNS. Precision’s allogeneic CAR T pipeline consists of multiple investigational candidates in early-stage clinical trials, including its first and second generation CD19 targeting candidates PBCAR0191 and PBCAR19B for relapsed and/or refractory (R/R) non-Hodgkin and B-cell lymphoma patients. Precision has also prioritized development of PBCAR269A, its BCMA targeted candidate in combination with a gamma secretase inhibitor for R/R patients with multiple myeloma. Precision BioSciences and its in-house manufacturing facility for AAV, mRNA, and CAR T cells is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com
Stock Symbol: DTIL
Stock Exchange: NASDAQ
- Website
- http://www.precisionbiosciences.com/
- Phone
- 919-314-5512
- Location
-
302 East Pettigrew Street
Durham
North Carolina
27701
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert